Wealthfront Advisers LLC bought a new position in shares of agilon health, inc. (NYSE:AGL – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 26,686 shares of the company’s stock, valued at approximately $51,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Oak Thistle LLC bought a new stake in agilon health in the fourth quarter valued at approximately $25,000. Ieq Capital LLC bought a new stake in agilon health in the fourth quarter valued at approximately $26,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in agilon health in the third quarter valued at approximately $28,000. Raymond James Financial Inc. bought a new stake in agilon health in the fourth quarter valued at approximately $33,000. Finally, Symphony Financial Services Inc. raised its stake in agilon health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock valued at $44,000 after buying an additional 7,058 shares during the period.
Analyst Upgrades and Downgrades
AGL has been the topic of several research analyst reports. Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Wednesday, February 26th. Sanford C. Bernstein upped their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and upped their target price for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Royal Bank of Canada upped their target price on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Finally, Stifel Nicolaus upped their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $3.95.
agilon health Trading Up 3.2 %
Shares of NYSE:AGL opened at $4.34 on Wednesday. The business’s 50 day simple moving average is $3.39 and its 200 day simple moving average is $2.93. The company has a market capitalization of $1.79 billion, a P/E ratio of -4.61 and a beta of 0.67. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than agilon health
- Growth Stocks: What They Are, Examples and How to Invest
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Short Selling: How to Short a Stock
- 3 Must-Own Stocks to Build Wealth This Decade
- Stock Dividend Cuts Happen Are You Ready?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.